Uses of Mycocox E 450 mg/300 mg/800 mg Tablet
Mycocox E 450 mg/300 mg/800 mg Tablet is used for the treatment or prevention of the following disease(s):
Tuberculosis (TB)
Side effects of Mycocox E 450 mg/300 mg/800 mg Tablet
Precautions while taking Mycocox E 450 mg/300 mg/800 mg Tablet
Dosage of Mycocox E 450 mg/300 mg/800 mg Tablet
Overdose of Mycocox E 450 mg/300 mg/800 mg Tablet
Onset of Action of Mycocox E 450 mg/300 mg/800 mg Tablet
Duration of Action of Mycocox E 450 mg/300 mg/800 mg Tablet
Precautions & Warnings
Alcohol
Information will be added soon.
Pregnancy
Information will be added soon.
Breastfeeding
Information will be added soon.
Driving
Information will be added soon.
Kidney
Information will be added soon.
Liver
Information will be added soon.
All substitutes for Mycocox E 450 mg/300 mg/800 mg Tablet
For information purpose only. Refer to a healthcare professionals before consuming any medicines and/or drugs.
Interactions
Drug :-
aminophylline, oxtriphylline, theophylline: Increased metabolism and clearance of these theophylline preparations.
anesthetics hydrocarbon inhalation, except isoflurane, hepatotoxic drugs, isoniazid: Increased risk of hepatotoxicity.
beta blockers, chloramphenicol, clofibrate, corticosteroids, cyclosporine, dapsone, digitalis glycosides, disopyramide, hexobarbital, itraconazole, ketoconazole, mexiletine, oral anticoagulants, oral antidiabetic drugs, phenytoin, propafenone, quinidine, tocainide, verapamil oral: Increased metabolism, resulting in lower blood levels of these drug.
bone marrow depressants: Increased leukopenic or thrombocytopenic effects.
clofazimine: Reduced absorption of rifampin, delaying its peak concentration and increasing its half-life.
diazepam: Enhanced diazepam elimination, resulting in decreased drug effectiveness.
estramustine, estrogens, oral contraceptives: Decreased estrogenic effects.
methadone: Possibly impaired absorption of methadone, leading to withdrawal symptoms.
probenecid: Increased blood level or prolonged duration of rifampin, increasing risk of toxicity.
nonnucleoside reverse transcriptase inhibitors, protease inhibitors indinavir, nelfinavir, ritonavir, saquinavir: Accelerated metabolism of these drugs by patients with HIV, resulting in subtherapeutic levels,delayed metabolism of rifampin, increasing risk of toxicity.
trimethoprim: Increased elimination and shortened elimination half-life of trimethoprim.
vitamin D: Increased metabolism and decreased efficacy of vitamin D, leading to decreased serum calcium and phosphate levels and increased parathyroid hormone levels.
Activity :-
alcohol use: Increased risk of hepatotoxicity.
Kunal is a registered pharmacist with RGUHS with over 4 years experience. He is a medicine content contributor at Health-Shoppe.com.
Dr. Naresh Dang is an MD in Internal Medicine. He has special interest in the field of Diabetes, and has over two decades of professional experience in his chosen field of specialty. Dr. Dang is an expert in the management of Diabetes, Hypertension and Lipids. He also provides consultation for Life Style Management.